Prof. Micheal Hamblin Harvard Medical School

Posted on 8 November 2011 by James Carroll

Photobiomodulation/Low Level Laser Therapy (LLLT) mechanisms and dose response.

About James Carroll

Founder and CEO at THOR Photomedicine Ltd. About THOR
This entry was posted in Information Videos, Interviews, Video of the Week. Bookmark the permalink.